We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Pathogenic Yeasts Quantified by Flow Cytometry

By LabMedica International staff writers
Posted on 12 Feb 2013
Print article
A flow cytometric, single-stain approach to quantify Candida albicans has been investigated as an alternative to the standard viable plate count.

In clinical settings, viable plate counts (VPC) are used to determine the patient's microbial load, but it is labor intensive, time consuming, and only allows detection of those organisms that readily grow on solid media.

Microbiologists at the University of Antwerp (Belgium) investigated a single-stain, flow cytometric approach for the enumeration of viable C. albicans cells. This single-stain strategy is based on the differences in the fluorescence intensity between viable and nonviable cells. In this study, the cells with an intact membrane are considered alive, while the cells with a damaged membrane are defined as dead.

Cell samples were stained with TO-PRO-3 iodide (TP3; Molecular Probes, OR, USA) which has a peak excitation at 642 nm with emission at 661 nm. All flow cytometry (FCM) studies were performed using a FACSCalibur flow cytometer (BD Biosciences, NJ, USA) equipped with a red diode laser (excitation at 633 nm) and a band pass filter measuring red fluorescence (FL4; range 653–669 nm). Molecular Probes' CountBright absolute counting beads were added to the samples as an internal standard to calculate the exact volume analyzed by the flow cytometer.

The authors concluded that the FCM quantification of viable cells using TP3 is a good alternative for the more time consuming and labor-intensive VPC. In comparison to other FCM techniques, this single-stain procedure is simple to apply and cost-effective since only one dye needs to be added. Moreover, the unique excitation/emission profile of TP3 allows the application of additional dyes to assess other cellular parameters with minimal spectral overlap. The study is planned for publication in print on February 15, 2013, in the Journal of Microbiological Methods.

Related Links:

University of Antwerp
Molecular Probes
BD Biosciences



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.